Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

JP Desager, Y Horsmans - Clinical pharmacokinetics, 1996 - Springer
Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase is the key enzyme of
cholesterol synthesis. HMG-CoA reductase inhibitors are potent reversible inhibitors of this …

Sterol absorption by the small intestine

SD Turley, JM Dietschy - Current opinion in lipidology, 2003 - journals.lww.com
Intestinal cholesterol absorption represents a major route for the entry of cholesterol into the
body's miscible pools and therefore can potentially impact the plasma LDL-cholesterol …

EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones

European Association for the Study Of the Liver - Journal of hepatology, 2016 - Elsevier
Gallstones or cholelithiasis are a major public health problem in Europe and other
developed countries and affect up to 20% of the population. Gallstone disease is the most …

Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial

CM Ballantyne, J Houri, A Notarbartolo, L Melani… - Circulation, 2003 - Am Heart Assoc
Background—Despite the established efficacy of statins, many patients do not achieve
recommended LDL cholesterol (LDL-C) goals. Contributing factors may be inadequate …

[图书][B] Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II).

National Cholesterol Education Program (US). Expert … - 1993 - books.google.com
Dr. DeWitt Goodman had agreed to be a member of this second Adult Treatment Panel at
the time of his dismayingly early death in November 1991. Dr. Goodman served with …

Effects of legume consumption on serum cholesterol, biliary lipids, and sterol metabolism in humans

WC Duane - Journal of lipid research, 1997 - ASBMB
Legume consumption appears to lower serum cholesterol and to increase cholesterol
saturation of bile, but the mechanisms of these effects have not been established. We …

Statin use and the risk of cholecystectomy in women

CJ Tsai, MF Leitzmann, WC Willett, EL Giovannucci - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Statins can reduce biliary cholesterol secretion independently of
their ability to inhibit cholesterol synthesis. Statins also prevent the formation of gallstones in …

Combination therapy of rosuvastatin and ezetimibe in patients with high cardiovascular risk

YJ Yang, SH Lee, BS Kim, YK Cho, HJ Cho… - Clinical …, 2017 - Elsevier
Purpose The aim of this study was to evaluate the efficacy and tolerability of
rosuvastatin/ezetimibe combination therapy in Korean patients with high cardiovascular risk …

Current views on genetics and epigenetics of cholesterol gallstone disease

A Di Ciaula, DQH Wang, L Bonfrate, P Portincasa - Cholesterol, 2013 - Wiley Online Library
Cholesterol gallstone disease, one of the commonest digestive diseases in western
countries, is induced by an imbalance in cholesterol metabolism, which involves intestinal …

α-Asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats

L Rodríguez-Páez, M Juárez-Sanchez, J Antúnez-Solís… - Phytomedicine, 2003 - Elsevier
Our results showed that α-asarone was an inhibitor of hepatic HMG-CoA reductase and that
the administration of α-asarone at 80 mg/kg body wt. for 8 days decreased serum cholesterol …